Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Galmed Pharmaceutica (GLMD)

Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Galmed Pharmaceuticals: Q3 Earnings Snapshot AP - Fri Nov 15, 7:29AM CST

Galmed Pharmaceuticals: Q3 Earnings Snapshot

GLMD : 2.80 (-5.41%)
MarketBeat Week in Review – 9/16 - 9/20 MarketBeat - Sat Sep 21, 6:00AM CDT

Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals

NVDA : 146.67 (+0.53%)
GOOGL : 167.63 (-4.74%)
AAPL : 228.52 (-0.21%)
MU : 102.76 (+4.46%)
ZG : 79.26 (+5.68%)
COIN : 295.23 (-7.74%)
DAL : 63.34 (-0.47%)
ASTS : 24.14 (+2.35%)
MSFT : 412.87 (-0.63%)
SHOP : 106.48 (+2.44%)
BYND : 5.01 (-2.72%)
MA : 515.10 (+0.50%)
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs FinancialNewsMedia - Fri Sep 20, 8:00AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END

ONCY : 0.9800 (-1.85%)
MRK : 99.86 (+2.48%)
NVS : 103.85 (+0.74%)
ONC.TO : 1.37 (-2.14%)
GLMD : 2.80 (-5.41%)
PFE : 25.13 (+0.76%)
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs GlobeNewswire - Fri Sep 20, 8:00AM CDT

ONCY : 0.9800 (-1.85%)
MRK : 99.86 (+2.48%)
NVS : 103.85 (+0.74%)
ONC.TO : 1.37 (-2.14%)
GLMD : 2.80 (-5.41%)
PFE : 25.13 (+0.76%)
Author
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? MarketBeat - Tue Sep 17, 1:40PM CDT

Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.

GLMD : 2.80 (-5.41%)
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? Motley Fool - Sun Mar 17, 4:50AM CDT

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

GALT : 2.72 (-3.37%)
GLMD : 2.80 (-5.41%)
VKTX : 51.63 (+0.19%)
ETNB : 8.38 (+5.01%)
IVA : 2.66 (-2.92%)
SGMT : 4.50 (-0.44%)
TERN : 5.71 (+1.96%)
NVO : 102.63 (-2.51%)
IQV : 197.60 (+1.66%)
MDGL : 329.24 (+3.83%)
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 2.80 (-5.41%)
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire - Fri Sep 22, 2023

/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 2.80 (-5.41%)
Galmed Pharmaceuticals: Q2 Earnings Snapshot AP - Thu Aug 10, 2023

Galmed Pharmaceuticals: Q2 Earnings Snapshot

GLMD : 2.80 (-5.41%)
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering PR Newswire - Fri Jul 14, 2023

/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...

GLMD : 2.80 (-5.41%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot